Business

Voyageur Announces Closing of Financing, Issuing of Stock Options and Extension of Warrants

(via TheNewswire) CALGARY, Alberta - TheNewswire - December 30 th , 201...

articleVoyageur Pharmaceuticals LtdDecember 30, 20193/company/voyageur-pharmaceuticals-ltd/news/voyageur-announces-closing-of-financing-issuing-of-stock-options-and-extension-of-warrants
Voyageur Announces Closing of Financing, Issuing of Stock Options and Extension of Warrants

About this update from Voyageur Pharmaceuticals Ltd

[{"type":"text","content":"Voyageur Announces Closing of Financing, Issuing of Stock Options and Extension of Warrants(via TheNewswire)\n \n \n\n\n \n \nCALGARY, Alberta - TheNewswire - December 30th, 2019, Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the \"Company\" or \"Voyageur\") announces the following.\n\n \n \nExtension of Warrants\n\n \n \nVoyageur announces that it has received acceptance from the TSX Venture Exchange for the extension of the term of 5,513,752 common share purchase warrants, originally set to expire on various dates in December 2019, now expiring on December 31, 2020. Each warrant is exercisable at a price of $0.15 per share.\n\n \n \nFinancing:\n\n \n \nVoyageur is pleased to announce that the Company has raised a total of $59,600 through the issuance of 745,000 flow-through units (the \"Units\"). Each Unit is comprised of one common share and one common share purchase warrant (a \"Warrant\"). Each Warrant is exercisable for one common share at a price of $0.20 per share for a period of 24 months from the date of closing. The Warrant also contain an acceleration clause whereby if the trading price of the Company's common shares exceeds $0.25 for 10 consecutive days, the Company may accelerate the expiration date of the Warrants by providing notice to holders of the Warrants that the Warrants will accelerate 30 days after the date of such notice is given. The subscription price of $0.08 per Unit will be renounced as flow through expense.\n\n \n \nThe Company paid a finder's fee of $3,968 and 49,600 broker warrants to arm's length dealers in connection with this private placement. Net proceeds from this private placement will be used to meet the Company's commitment under its work program and for general working capital purposes. The securities issued pursuant to the private placement will be subject to a four month hold period expiring April 24, 2020.\n\n \n \nSubsequent to this private placement the Company will have 67,576,038 shares issued and outstanding.\n\n \n \nVoyageur has now closed all of its current financing at $0.075 per share and full $0.20/share warrant, and the flow through offering of $0.08 per share with a full $0.20/share warrant. \n\n \n \nIssuance of Stock Options\n\n \n \nVoyageur announces that it has reserved 3,000,000 common shares under stock option to be issued as follows:\n\n \n \n 825,000 to executive off...

More updates from Voyageur Pharmaceuticals Ltd